Améndola R et al. |
[Is dental plaque a normal Helicobacter pylori reservoir?]. |
1998 |
Acta Gastroenterol. Latinoam. |
pmid:9713656
|
Bergmann JS and Woods GL |
In vitro activity of antimicrobial combinations against clinical isolates of susceptible and resistant Mycobacterium tuberculosis. |
1998 |
Int. J. Tuberc. Lung Dis. |
pmid:9712275
|
Fernández Bermejo M and GarcÃa Grávalos R |
[Ebrotidine in the eradicating treatment of H. pylori]. |
1998 Jun-Jul |
Gastroenterol Hepatol |
pmid:9711019
|
Burman WJ et al. |
Long-term outcomes of treatment of Mycobacterium avium complex bacteremia using a clarithromycin-containing regimen. |
1998 |
AIDS |
pmid:9708410
|
van der Wouden EJ et al. |
One-week triple therapy with ranitidine bismuth citrate, clarithromycin and metronidazole versus two-week dual therapy with ranitidine bismuth citrate and clarithromycin for Helicobacter pylori infection: a randomized, clinical trial. |
1998 |
Am. J. Gastroenterol. |
pmid:9707042
|
Wang G et al. |
Genotypic characterization of clarithromycin-resistant and -susceptible Helicobacter pylori strains from the same patient demonstrates existence of two unrelated isolates. |
1998 |
J. Clin. Microbiol. |
pmid:9705423
|
Ellenrieder V et al. |
Influence of clarithromycin dosage on pantoprazole combined triple therapy for eradication of Helicobacter pylori. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9701524
|
Takizawa H et al. |
Erythromycin and clarithromycin attenuate cytokine-induced endothelin-1 expression in human bronchial epithelial cells. |
1998 |
Eur. Respir. J. |
pmid:9701415
|
Fennerty MB et al. |
A comparison of 10 and 14 days of lansoprazole triple therapy for eradication of Helicobacter pylori. |
1998 Aug 10-24 |
Arch. Intern. Med. |
pmid:9701099
|
Hsieh PF et al. |
Molecular mechanisms of clarithromycin resistance in Helicobacter pylori. |
1998 |
J. Formos. Med. Assoc. |
pmid:9700240
|
Wakasugi H et al. |
Effect of clarithromycin on renal excretion of digoxin: interaction with P-glycoprotein. |
1998 |
Clin. Pharmacol. Ther. |
pmid:9695727
|
Hashimoto Y |
[Eradication therapies for Helicobacter pylori]. |
1998 |
Kansenshogaku Zasshi |
pmid:9695480
|
Habu Y et al. |
Triple therapy with omeprazole, amoxicillin and clarithromycin is effective against Helicobacter pylori infection in gastric ulcer patients as well as in duodenal ulcer patients. Results of a randomized controlled trial in Japan. |
1998 Jul-Aug |
Digestion |
pmid:9693202
|
Dobrilla G et al. |
Ranitidine bismuth citrate with either clarithromycin 1 g/day or 1.5 g/day is equally effective in the eradication of H. pylori and healing of duodenal ulcer. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9692703
|
Catalano F et al. |
Ranitidine bismuth citrate versus omeprazole triple therapy for the eradication of Helicobacter pylori and healing of duodenal ulcer. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9692702
|
Bardhan KD et al. |
Pantoprazole-based 10-day triple therapy is effective in Helicobacter pylori eradication. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9692693
|
Soepandi P et al. |
The pattern of micro-organisms and the efficacy of new macrolide in acute lower respiratory tract infections. |
1998 |
Respirology |
pmid:9692520
|
Bigard MA et al. |
One-week triple therapy using omeprazole, amoxycillin and clarithromycin for the eradication of Helicobacter pylori in patients with non-ulcer dyspepsia: influence of dosage of omeprazole and clarithromycin. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9690730
|
Portaels F et al. |
In vitro susceptibility of Mycobacterium ulcerans to clarithromycin. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9687409
|
Martin SJ and Pendland SL |
Bactericidal activity and postantibiotic effect of clarithromycin and 14-hydroxyclarithromycin, alone and in combination, against Legionella pneumophila. |
1998 |
J. Antimicrob. Chemother. |
pmid:9687103
|